MS Pharma & Kashiv Biosciences enter licensing and supply pact for commercialization of ADL-018/bOmalizumab in the MENA region: Jordan Thursday, August 7, 2025, 11:00 Hrs [IST] MS ...

Kashiv BioSciences, LLC and MS Pharma today announced that the companies have entered into a license and supply agreement for ...

Spruce Biosciences (SPRB) announces a 1-for-75 reverse stock split effective Aug 4, 2025, to meet Nasdaq requirements.

Press Releases Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform ...

Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform Written by xenetic biosciences inc.

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC ...

According to the technical analysis of over 4,400 firms with a market cap exceeding $100 million, three firms are in the overbought zone.

Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s, Further Strengthening its Global ...

Fintel reports that on July 10, 2025, Goldman Sachs initiated coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a Buy recommendation. Analyst Price Forecast Suggests 19.10% Upside As of June ...